Skip to main content
. Author manuscript; available in PMC: 2022 Dec 2.
Published in final edited form as: Cancer Discov. 2022 Jun 2;12(6):1580–1597. doi: 10.1158/2159-8290.CD-20-1484

Figure 4. FAP+ and αSMA+ CAFs distinctly polarize the PDAC tumor immune microenvironment.

Figure 4.

(A-B) Differentially regulated genes in endpoint FAP+ CAF-depleted and αSMA+ CAF-depleted KTC tumors. (A) Volcano plots of downregulated and upregulated genes in FAP+ CAF-depleted and αSMA+ CAF-depleted KTC tumors. n=3 mice per group. (B) Unique and common downregulated and upregulated genes in FAP+ CAF-depleted and αSMA+ CAF-depleted KTC tumors.

(C-D) GSEA pathways identified after depletion of FAP+ (C) or αSMA+ cells (D) from KTC tumors.

(E) CIBERSORT analysis of abundance of immune cell subsets in FAP+ CAF-depleted and αSMA+ CAF-depleted KTC tumors. n=3 mice per group.

(F) Multiplex immunohistochemical analysis of tumor immune infiltrate of endpoint FAP+ CAF-depleted and αSMA+ CAF-depleted KTC mice (top panel). Scale bar: 100μm. Quantification of Teff/Treg ratio (bottom left panel) and percent CD3+CD8+ cells (bottom right panel). n=7 mice per group. One-way ANOVA and unpaired two-tailed t-test performed comparing control to depleted mice. * p < 0.05, ns = not significant.